Saved in:
| Main Author: | |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2505.12848 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- The development of novel pharmaceuticals represents a significant challenge in modern science, with substantial costs and time investments. Deep generative models have emerged as promising tools for accelerating drug discovery by efficiently exploring the vast chemical space. However, this rapidly evolving field lacks standardized evaluation protocols, impeding fair comparison between approaches. This research presents an extensive analysis of the Molecular Sets (MOSES) platform, a comprehensive benchmarking framework designed to standardize evaluation of deep generative models in molecular design. Through rigorous assessment of multiple generative architectures, including recurrent neural networks, variational autoencoders, and generative adversarial networks, we examine their capabilities in generating valid, unique, and novel molecular structures while maintaining specific chemical properties. Our findings reveal that different architectures exhibit complementary strengths across various metrics, highlighting the complex trade-offs between exploration and exploitation in chemical space. This study provides detailed insights into the current state of the art in molecular generation and establishes a foundation for future advancements in AI-driven drug discovery.